What must the nurse obtain from the patient in order for medical information to be released to another health care facility or third party regarding a patient diagnosed with a mental illness?

Choice A reason: Administering an antipsychotic without a completed care plan risks inappropriate treatment, as the plan outlines specific needs and interventions. This could lead to adverse effects or mismanagement of the patient’s condition, violating evidence-based practice in psychiatric care, making this choice incorrect.

Choice B reason: Completing the care plan promptly ensures individualized, evidence-based interventions, critical for effective psychiatric treatment. It addresses the patient’s specific needs, guides therapy, and ensures safety, aligning with nursing standards and patient-centered care principles, making this the correct choice for prioritization.

Choice C reason: Transferring the patient to another unit does not address the immediate need for a care plan and may disrupt continuity of care. Staffing issues should be managed locally, and transfer is not a primary solution for incomplete planning, making this choice incorrect.

Choice D reason: Documenting staffing issues, while important for administrative purposes, does not directly address the patient’s immediate care needs. A completed care plan is critical for guiding treatment and ensuring safety, making this choice a lower priority compared to completing the plan.

Choice A reason: GABA, an inhibitory neurotransmitter, reduces neuronal activity, not enhances cognitive functions like memory. Memory improvement is associated with cholinergic or glutamatergic systems, not GABA, making this choice incorrect for the expected effect of GABA potentiation.

Choice B reason: Fewer visual hallucinations are associated with antipsychotics affecting dopamine, not GABA. GABA’s inhibitory effects calm the brain but do not directly target psychotic symptoms like hallucinations, making this choice incorrect for the medication’s effect.

Choice C reason: GABA potentiation, as with benzodiazepines, enhances inhibitory effects, reducing neuronal excitability and calming the central nervous system. This directly alleviates anxiety, a primary therapeutic effect, aligning with GABA’s role in anxiety disorders, making this the correct choice.

Choice D reason: Increased alertness is contrary to GABA’s inhibitory effects, which promote sedation. Stimulants, not GABAergic drugs, enhance alertness, making this choice incorrect, as GABA potentiation leads to calming, not stimulating, effects on the brain.